• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A study of the endothelial function for blood vessels with angiopathic stroke in childhood.

Research Project

Project/Area Number 10670771
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionKURUME UNIVERSITY SCHOOL OF MEDICINE

Principal Investigator

IWANAGA Rikako  Department of Pediatrics and Child Health, Kurume University of School Medicine., 医学部, 助手 (20258396)

Co-Investigator(Kenkyū-buntansha) MATSUISHI Toyojiro  Department of Pediatrics and Child Health, Kurume University of School Medicine., 医学部, 助教授 (60157237)
KOGA Yasutoshi  Department of Pediatrics and Child Health, Kurume University of School Medicine., 医学部, 講師 (00225400)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 2000: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1999: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1998: ¥700,000 (Direct Cost: ¥700,000)
KeywordsMELAS / Angiopathy / stroke / endothelial function / mitochondrial DNA / single fiber PCR / 脳卆中 / 血管障害 / NOS / mtDNA / 点変異 / ミトコンドリア病
Research Abstract

MELAS(mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes)is characterized by stroke before 20 years old, mitochondrial angiopathy demonstrating degenerative change with increased abnormal mitochondria in the endothelial cells of intramuscular small arteries and arterioles have been reported in many MELAS patients. However, the primary cause of the young MELAS strokelike episodes, either mitochondreial cytopathy or angiopathy, or both is still controversial. Since abnormal mitochondria generates superoxide anion, we hypothesized that vascular complications in MELAS may be associated with endothelial dysfunction caused by oxidative stress. Nine patients were clinically, muscle pathologically or genetically diagnosed as MELAS.Six patients have an A3243G mutation, one patient has a T3271C mutation in the mitochondrial tRNALeu(UUR)gene, and two patients have not been found their genetic abnormality. In this study, we examined flow-mediated vasodilatation, as a … More non-invasive measure of endothelial function, and effect of an antioxidant, vitamin C in patient with MELAS.We analyzed the correlationship between the amount of point mutation in the endothelial cell and the endothelial function by single-cell PCR analysis. We also studied the pharmacological effect on the clinical course, and biochemical parameters after administration of L-arginine to a patient in the acute phase of stroke on three separated occasions, and on the functional aspects of the cerebral hemodynamics using single photon emission computed tomography(SPECT). Flow-mediated vasodilatation was significantly less(10% of the age-matched controls)in MELAS patients. Endothelium dependent vasodilatation included by glyceryl trinitrate was also impaired. Vitamin C administration significantly restored flow-mediated dilatation and gryceryl trinitrate-included vasodilatation to near-normal levels in MELAS but did not affect them in controls. After the administration of L-arginine, all the symptoms of the patient suggesting the strokelike episode were clinically improved. On SPECT using ECD, the intracranial hemodynamics were also improved in the ischemic area(in the left temporal lobe), but unchanged in the brain stem(thalamus). There are clear inverse correlationships between the amount of point mutation and the capacity of endothelial dependent-vasodilatation in the endothelial cells. Our data demonstrated that angiopathy seen in MELAS involved abnormality in the capacity of vasodilatation in the endothelial system, which may play an important role in causing strokelike episodes in this disorder. Less

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (27 results)

All Other

All Publications (27 results)

  • [Publications] Koga Y,Yoshino M,Kato H.: "MELAS exhibits dominant negative effects on mitochondrial RNA processing."Ann Neurol. 43. 83 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koga Y,Iwanaga T,Yoshida I,Yoshino M,kaneko S,Kato H.: "Maple syrup urine disease:Nutritional management by intravenous hyperalimentation and uneventful course after surgical repair of dislocation of the hip."J Inher Metab dis. 21. 177-178 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sobreira C,King M,Davidson M,Park H,Koga Y,Miranda A.: "Long-term analysis of differentiation in human myoblast repopulated with mitochondria harboring mtDNA mutations."Biochem Biophys Res Commun. 266. 179-186 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Bruno C,Shanske S,Koga Y,Iwanaga R,Akita Y,Dimauro S.: "The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeltal myopathy."J pediatr . 135. 197-202 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yoshino M,Aoki K,Koga Y,Yano S,Yoshioka A. : "Managiment of acute metabolic decompensation in maple syrup urine:A multi-center study."Pediatr Int. 41. 132-137 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akita Y,Koga Y,Iwanaga R,Wada N,Nakamura Y,Kato H.: "Fatal hypertrophic cardimyopathy associated with an A8296G mutation in the mitochondrial tRNALys gene."Human Mutation. #306. 1-7 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koga Y, Yoshino M, Kato H.: "MELAS exhibits dominant negative effects on mitochondrial RNA processing."Ann Neurol. 43. 83 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koga Y, Iwanaga T, Yoshida I, Yoshino M, kaneko S, Kato H.: "Maple syrup urine disease : Nutritional management by intravenous hyperalimentation and uneventful course after surgical repair of dislocation of the hip."J Inher Metab dis. 21. 177-178 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sobreira C, King M, Davidson M, Park H, Koga Y, Miranda A.: "Long-term analysis of differentiation in human myoblast repopulated with mitochondria harboring mtDNA mutations."Res Commun. 266. 179-186 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Bruno C, Shanske S, Santorelli F, Koga Y, Iwanaga R, Akita Y, Dimauro S.: "The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeltal myopathy."J pediatr. 135. 197-202 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yoshino M, Aoki K, Akeda H, Hashimoto K, Ikeda T, Koga y, Yano S, Yoshioka A.: "Managiment of acute metabolic decompensation in maple syrup urine : A multi-center study."Pediatr Int. 41. 132-137 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akita Y, Koga Y, Iwanaga R, Wada N, Tsubone J, Fukuda S, Nakamura Y, Kato H.: "Fatal hypertrophic cardimyopathy associated with an A8296G mutation in the mitochondrial tRNALys gene."Human Mutation. #306 online. 1-7 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koga Y, Koga A, Iwanaga R, Akita Y, Tubone J, Matsuishi T, Sato Y, Kato H.: "Single fiber analysis of mitochondrial A3243G mutation in four different phenotypes."Acta Neuropathol. 99. 186-190 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koga Y, Akita Y, Takane N, Sato Y, Kato H.: "Heterogenuous presentation in A3243G mutation in the mitochondrial tRNALeu(UUR)gene."Arch Dis Child. 82. 107-411 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iwanaga R, Koga Y, Aramaki S, Kato S, Kato H.: "Inter-and/or intraorgan distribution of mitochondrial C3303T or A3243G mutation in mitochondrial cytopathy."Acta Neuropathol. 101. 179-184 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Murakami Y, Yamashita Y, Matsuishi T, Iwanaga R, Kato H.: "Cerebral oxygenation and hemodynamics during hyperventilation and sleep in patients with Rett syndrame."Brain Dev. 20. 574-578 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koga Y, et al: "Heterogenous presentation in A3243G mutation in the mitochoundrial tRNALeu (UUR) gene."Archives Disease in Childhood. 85(5). 407-411 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Iwanaga R, et al: "Inter-and/or intra-organ distribution of mitochondrial C3303T or A3243G mutation in mitochondrial cytopathy."Acta Neuropathol (Berl). 101. 179-184 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Akita Y,Iwanaga R,et al: "Fatal obstructive hypertrophic cardiomyopathy assosiated with A8256G mutation in the mitochondrial tRNALys gene."Human Mutatin in brief. Web#306. 1-7 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Koga Y,Iwanaga R,et al: "Single fiber analysis of mitochondrial A3243G mutation in four different phenotype."Acta Neuropathologica. 99. 186-190 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Bruno C,Kirby DM,Iwanaga R,et al: "The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeletal myopathy."Jounal of Pediatrics. 135. 197-202 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Murakami Y,et al.: "Cerebral oxygenation and hemodysmics during hyperusntilation and sleep in patiemts with Rett syndrome." Brain & Development. 20(8). 574-578 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] D.Mauro S,et al.: "the mitochondrial DNA C3303T point mutation can cause cardiomyopathy,myopathy,(or both)" J.Pediatr.in press. (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Koga Y.et al.: "MELAS exhibits dominant negative effects on mitochondrial RNA processing." Annals of Neurology. 43. 835 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Koga Y.et al.: "Maple syrup urine disease:nutritional management by intravenous hyperalimentations and uneventful course after surgical repair." J.Inherted Metabolic Diseases. 21. 177-178 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Nezu J.et al: "Primary systemic carnitine deficiency is caused by mutations in a gene encoding ion-deoendent carnitine transporter." Nature Genetics. 21(1). 91-94 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Murakami Y.et al.: "Cranial MRI of neurologically impaired children suffering from neonatal hypergeycaemis" Pediatr Radiol. 29(1). 23-27 (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi